Boston Scientific Statistics
Total Valuation
BSX has a market cap or net worth of $152.83 billion. The enterprise value is $164.32 billion.
Market Cap | 152.83B |
Enterprise Value | 164.32B |
Important Dates
The last earnings date was Wednesday, July 23, 2025, before market open.
Earnings Date | Jul 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BSX has 1.48 billion shares outstanding. The number of shares has increased by 0.78% in one year.
Current Share Class | 1.48B |
Shares Outstanding | 1.48B |
Shares Change (YoY) | +0.78% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 0.18% |
Owned by Institutions (%) | 91.57% |
Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 61.39 and the forward PE ratio is 33.19. BSX's PEG ratio is 2.43.
PE Ratio | 61.39 |
Forward PE | 33.19 |
PS Ratio | 8.23 |
Forward PS | 7.39 |
PB Ratio | 6.81 |
P/TBV Ratio | n/a |
P/FCF Ratio | 43.85 |
P/OCF Ratio | 35.67 |
PEG Ratio | 2.43 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.92, with an EV/FCF ratio of 47.15.
EV / Earnings | 65.60 |
EV / Sales | 8.89 |
EV / EBITDA | 34.92 |
EV / EBIT | 48.47 |
EV / FCF | 47.15 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.53.
Current Ratio | 1.37 |
Quick Ratio | 0.65 |
Debt / Equity | 0.53 |
Debt / EBITDA | 2.50 |
Debt / FCF | 3.45 |
Interest Coverage | 10.24 |
Financial Efficiency
Return on equity (ROE) is 11.55% and return on invested capital (ROIC) is 6.40%.
Return on Equity (ROE) | 11.55% |
Return on Assets (ROA) | 5.39% |
Return on Invested Capital (ROIC) | 6.40% |
Return on Capital Employed (ROCE) | 9.32% |
Revenue Per Employee | $348,943 |
Profits Per Employee | $47,264 |
Employee Count | 53,000 |
Asset Turnover | 0.47 |
Inventory Turnover | 2.16 |
Taxes
In the past 12 months, BSX has paid $502.00 million in taxes.
Income Tax | 502.00M |
Effective Tax Rate | 16.73% |
Stock Price Statistics
The stock price has increased by +39.79% in the last 52 weeks. The beta is 0.66, so BSX's price volatility has been lower than the market average.
Beta (5Y) | 0.66 |
52-Week Price Change | +39.79% |
50-Day Moving Average | 103.64 |
200-Day Moving Average | 98.36 |
Relative Strength Index (RSI) | 44.94 |
Average Volume (20 Days) | 7,571,015 |
Short Selling Information
The latest short interest is 19.57 million, so 1.32% of the outstanding shares have been sold short.
Short Interest | 19.57M |
Short Previous Month | 17.49M |
Short % of Shares Out | 1.32% |
Short % of Float | 1.32% |
Short Ratio (days to cover) | 2.65 |
Income Statement
In the last 12 months, BSX had revenue of $18.49 billion and earned $2.51 billion in profits. Earnings per share was $1.68.
Revenue | 18.49B |
Gross Profit | 12.58B |
Operating Income | 3.39B |
Pretax Income | n/a |
Net Income | 2.51B |
EBITDA | 4.71B |
EBIT | 3.39B |
Earnings Per Share (EPS) | $1.68 |
Balance Sheet
The company has $534.00 million in cash and $12.03 billion in debt, giving a net cash position of -$11.49 billion or -$7.76 per share.
Cash & Cash Equivalents | 534.00M |
Total Debt | 12.03B |
Net Cash | -11.49B |
Net Cash Per Share | -$7.76 |
Equity (Book Value) | 22.65B |
Book Value Per Share | 15.14 |
Working Capital | 1.93B |
Cash Flow
In the last 12 months, operating cash flow was $4.29 billion and capital expenditures -$800.00 million, giving a free cash flow of $3.49 billion.
Operating Cash Flow | 4.29B |
Capital Expenditures | -800.00M |
Free Cash Flow | 3.49B |
FCF Per Share | $2.35 |
Margins
Gross margin is 68.04%, with operating and profit margins of 18.33% and 13.55%.
Gross Margin | 68.04% |
Operating Margin | 18.33% |
Pretax Margin | 16.22% |
Profit Margin | 13.55% |
EBITDA Margin | 25.44% |
EBIT Margin | 18.33% |
FCF Margin | 18.84% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.78% |
Shareholder Yield | -0.78% |
Earnings Yield | 1.64% |
FCF Yield | 2.28% |
Analyst Forecast
The average price target for BSX is $118.32, which is 14.72% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $118.32 |
Price Target Difference | 14.72% |
Analyst Consensus | Strong Buy |
Analyst Count | 22 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 6, 2003. It was a forward split with a ratio of 2:1.
Last Split Date | Nov 6, 2003 |
Split Type | Forward |
Split Ratio | 2:1 |
Scores
BSX has an Altman Z-Score of 5.22 and a Piotroski F-Score of 5.
Altman Z-Score | 5.22 |
Piotroski F-Score | 5 |